Ophthalmological Adverse Events of Tralokinumab in AD
Condition: Atopic Dermatitis Intervention: Sponsors: Nantes University Hospital; LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials
Investigating the Safety of LEO 158968 in Healthy Volunteers
Condition: Healthy Volunteers Interventions: Drug: LEO 158968; Drug: Placebo Sponsor: LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials
Ophthalmological Adverse Events of Tralokinumab in AD
Condition: Atopic Dermatitis Intervention: Sponsors: Nantes University Hospital; LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials
Investigating the Safety of LEO 158968 in Healthy Volunteers
Condition: Healthy Volunteers Interventions: Drug: LEO 158968; Drug: Placebo Sponsor: LEO Pharma Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2023 Category: Research Source Type: clinical trials